QuidelOrtho Corp (QDEL)
43.40
+0.90
(+2.12%)
USD |
NASDAQ |
May 06, 16:00
43.38
-0.02
(-0.03%)
After-Hours: 20:00
QuidelOrtho Net Income (Quarterly): 7.00M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.00M |
| September 30, 2023 | -12.70M |
| June 30, 2023 | -53.20M |
| March 31, 2023 | 48.80M |
| December 31, 2022 | 30.30M |
| September 30, 2022 | 19.20M |
| June 30, 2022 | 19.30M |
| March 31, 2022 | 479.90M |
| December 31, 2021 | 291.30M |
| September 30, 2021 | 215.70M |
| June 30, 2021 | 19.10M |
| March 31, 2021 | 178.08M |
| December 31, 2020 | 470.13M |
| September 30, 2020 | 232.27M |
| June 30, 2020 | 67.65M |
| March 31, 2020 | 40.24M |
| December 31, 2019 | 30.63M |
| September 30, 2019 | 16.18M |
| June 30, 2019 | 1.27M |
| March 31, 2019 | 24.84M |
| December 31, 2018 | 32.48M |
| September 30, 2018 | 10.82M |
| June 30, 2018 | -3.076M |
| March 31, 2018 | 33.96M |
| December 31, 2017 | -5.088M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.525M |
| June 30, 2017 | -11.84M |
| March 31, 2017 | 14.29M |
| December 31, 2016 | -1.95M |
| September 30, 2016 | -0.572M |
| June 30, 2016 | -7.84M |
| March 31, 2016 | -3.446M |
| December 31, 2015 | -0.377M |
| September 30, 2015 | -0.762M |
| June 30, 2015 | -8.931M |
| March 31, 2015 | 3.991M |
| December 31, 2014 | 7.113M |
| September 30, 2014 | -5.767M |
| June 30, 2014 | -6.908M |
| March 31, 2014 | -1.512M |
| December 31, 2013 | 1.139M |
| September 30, 2013 | -4.361M |
| June 30, 2013 | -1.755M |
| March 31, 2013 | 12.37M |
| December 31, 2012 | 8.74M |
| September 30, 2012 | -0.676M |
| June 30, 2012 | -3.122M |
| March 31, 2012 | 0.051M |
| December 31, 2011 | 0.958M |
| September 30, 2011 | -1.113M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-53.20M
Minimum
Jun 2023
479.90M
Maximum
Mar 2022
110.59M
Average
30.63M
Median
Dec 2019
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 1.225B |
| Becton Dickinson & Co | 537.00M |
| Boston Scientific Corp | 492.00M |
| Tenon Medical Inc | -3.134M |
| Perspective Therapeutics Inc | -24.68M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 742.60M |
| Total Expenses (Quarterly) | 669.50M |
| EPS Diluted (Quarterly) | 0.10 |
| Enterprise Value | 5.149B |
| Gross Profit Margin (Quarterly) | 51.35% |
| Profit Margin (Quarterly) | 0.94% |
| Earnings Yield | -0.37% |
| Operating Earnings Yield | 8.70% |
| Normalized Earnings Yield | 1.984 |